Neuroprotective effects of Co-UltraPEALut on secondary inflammatory process and autophagy involved in traumatic brain injury

Journal of Neurotrauma

Volumn 33, Issue 1, 2016, Pages 132-146

  Cordaro, Marika ^a   Impellizzeri, Daniela ^a   Paterniti, Irene ^a   Bruschetta, Giuseppe ^a   Siracusa, Rosalba ^a   De Stefano, Daniela ^b   Cuzzocrea, Salvatore ^a,c   Esposito, Emanuela ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

autophagy; inflammation; luteolin; neuroprotection; palmitoylethanolamide

Indexed keywords

3 NITROTYROSINE; BECLIN 1; CHYMASE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LUTEOLIN; PALMIDROL; REACTIVE OXYGEN METABOLITE; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA; ANTIOXIDANT; CO-ULTRAPEALUT; DRUG COMBINATION; ETHANOLAMINE DERIVATIVE; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; COGNITION; CONTROLLED STUDY; CRANIOTOMY; CYTOKINE RELEASE; ENZYME ACTIVATION; MALE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN INJURIES; COMPLICATION; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECTS; INFLAMMATION;

ANIMALS; ANTIOXIDANTS; AUTOPHAGY; BRAIN INJURIES; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; ETHANOLAMINES; INFLAMMATION; LUTEOLIN; MALE; MICE; NEUROPROTECTIVE AGENTS;

EID: 84952940195     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2014.3460     Document Type: Article

References (66)

1. Narayan R.K, Michel M.E, Ansell B, Baethmann A, Biegon A, Bracken M.B, Bullock M.R, Choi S.C, Clifton G.L, Contant C.F, Coplin W.M, Dietrich W.D, Ghajar J, Grady S.M, Grossman R.G, Hall E.D, Heetderks W, Hovda D.A, Jallo J, Katz R.L, Knoller N, Kochanek P.M, Maas A.I, Majde J, Marion D.W, Marmarou A, Marshall L.F, McIntosh T.K, Miller E, Mohberg N, Muizelaar J.P, Pitts L.H, Quinn P, Riesenfeld G, Robertson C.S, Strauss K.I, Teasdale G, Temkin N, Tuma R, Wade C, Walker M.D, Weinrich M, Whyte J, Wilberger J, Young A.B, and Yurkewicz L. (2002). Clinical trials in head injury. J. Neurotrauma. 19, 503-557.
2. Xiong Y, Mahmood A, and Chopp M. (2010). Neurorestorative treatments for traumatic brain injury. Discov. Med. 10, 434-442.
3. Menon D.K, Schwab K, Wright D.W, Maas A.I, Demographics and Clinical Assessment Working Group of the International and Interagency Initiative toward Common Data Elements for Research on Traumatic Brain Injury and Psychological Health. (2010). Position statement: definition of traumatic brain injury. Arch. Phys. Med Rehabil. 91, 1637-1640.
4. Saatman K.E, Duhaime A.C, Bullock R, Maas A.I, Valadka A. and Manley G.T. (2008). Classification of traumatic brain injury for targeted therapies. J. Neurotrauma. 25, 719-738.
5. McIntosh T.K, Smith D.H, Meaney D.F, Kotapka M.J, Gennarelli T.A, and Graham D.I. (1996). Neuropathological sequelae of traumatic brain injury: relationship to neurochemical and biomechanical mechanisms. Lab. Invest. 74, 315-342.
6. Ziebell J.M, and Morganti-Kossmann M.C. (2010). Involvement of pro- And anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics. 7, 22-30.
7. Rhodes J. (2011). Peripheral immune cells in the pathology of traumatic brain injury? Curr. Opin. Crit. Care. 17, 122-130.
8. Ahmad A, Crupi R, Impellizzeri D, Campolo M, Marino A, Esposito E, and Cuzzocrea S. (2012). Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice. Brain, Behav. Immun. 26, 1310-1321.
9. Lucas S.M, Rothwell N.J, and Gibson R.M. (2006). The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147. Suppl. 1, S232-S240.
10. d'Avila J.C, Lam T.I, Bingham D, Shi J, Won S.J, Kauppinen T.M, Massa S, Liu J, and Swanson R.A. (2012). Microglial activation induced by brain trauma is suppressed by post-injury treatment with a PARP inhibitor. J. Neuroinflammation. 9, 31.
11. Shao C, Roberts K.N, Markesbery W.R, Scheff S.W, and Lovell M.A. (2006). Oxidative stress in head trauma in aging. Free Radic Biol. Med. 41, 77-85.
12. Ozdemir D, Uysal N, Gonenc S, Acikgoz O, Sonmez A, Topcu A, Ozdemir N, Duman M, Semin I, and Ozkan H. (2005). Effect of melatonin on brain oxidative damage induced by traumatic brain injury in immature rats. Physiol. Res. 54, 631-637.
13. Solaroglu I, Okutan O, Kaptanoglu E, Beskonakli E, and Kilinc K. (2005). Increased xanthine oxidase activity after traumatic brain injury in rats. J. Clin. Neurosci. 12, 273-275.
14. Ansari M.A, Ahmad A.S, Ahmad M, Salim S, Yousuf S, Ishrat T, and Islam F. (2004). Selenium protects cerebral ischemia in rat brain mitochondria. Biol. Trace Elem. Res. 101, 73-86.
15. Ansari M.A, Joshi G, Huang Q, Opii W.O, Abdul H.M, Sultana R, and Butterfield D.A. (2006). In vivo administration of D609 leads to protection of subsequently isolated gerbil brain mitochondria subjected to in vitro oxidative stress induced by amyloid beta-peptide and other oxidative stressors: relevance to Alzheimers disease and other oxidative stress-related neurodegenerative disorders. Free Rad. Biol. Med. 41, 1694-1703.
16. Lai Y, Hickey R.W, Chen Y, Bayir H, Sullivan M.L, Chu C.T, Kochanek P.M, Dixon C.E, Jenkins L.W, Graham S.H, Watkins S.C, and Clark R.S. (2008). Autophagy is increased after traumatic brain injury in mice and is partially inhibited by the antioxidant gammaglutamylcysteinyl ethyl ester. J. Cereb. Blood Flow Metab. 28, 540-550.
17. Klionsky D.J. (2005). The molecular machinery of autophagy: unanswered questions. J. Cell Sci. 118, 7-18.
18. Loos B, Engelbrecht A.M, Lockshin R.A, Klionsky D.J, and Zakeri Z. (2013). The variability of autophagy and cell death susceptibility: Unanswered questions. Autophagy. 9, 1270-1285.
19. Kline A.E, Wagner A.K, Westergom B.P, Malena R.R, Zafonte R.D, Olsen A.S, Sozda C.N, Luthra P, Panda M, Cheng J.P, and Aslam H.A. (2007). Acute treatment with the 5-HT(1A) receptor agonist 8-OH-DPAT and chronic environmental enrichment confer neurobehavioral benefit after experimental brain trauma. Behav. Brain Res. 177, 186-194.
20. Genovese T, Esposito E, Mazzon E, Di Paola R, Meli R, Bramanti P, Piomelli D, Calignano A, and Cuzzocrea S. (2008). Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury. J. Pharmacol. Exp. Ther. 326, 12-23.
21. Hansen H.S, Moesgaard B, Hansen H.H, and Petersen G. (2000). N-Acylethanolamines and precursor phospholipids-relation to cell injury. Chem. Phys. Lipids. 108, 135-150.
22. Walter L, Franklin A, Witting A, Moller T, and Stella N. (2002). Astrocytes in culture produce anandamide and other acylethanolamides. J. Biol. Chem. 277, 20869-20876.
23. Muccioli G.G, and Stella N. (2008). Microglia produce and hydrolyze palmitoylethanolamide. Neuropharmacology. 54, 16-22.
24. Berdyshev E, Boichot E, Corbel M, Germain N, and Lagente V. (1998). Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice. Life Sci. 63, PL125-129.
25. Lambert D.M, Vandevoorde S, Jonsson K.O, and Fowler C.J. (2002). The palmitoylethanolamide family: a new class of antiinflammatory agents? Curr. Med. Chem. 9, 663-674.
26. Calignano A, La Rana G, Giuffrida A, and Piomelli D. (1998). Control of pain initiation by endogenous cannabinoids. Nature. 394, 277-281.
27. Paterniti I, Impellizzeri D, Di Paola R, Navarra M, Cuzzocrea S, and Esposito E. (2013). A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury. J. Neuroinflammation. 10, 91.
28. Seelinger G, Merfort I, and Schempp C.M. (2008). Anti-oxidant, anti-inflammatory and anti-Allergic activities of luteolin. Planta Med. 74, 1667-1677.
29. Middleton E, Jr, Kandaswami C, and Theoharides T.C. (2000). The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 52, 673-751.
30. Schomacher M, Muller H.D, Sommer C, Schwab S, and Schabitz W.R. (2008). Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia. Brain Res. 1240, 213-220.
31. Hara H, Friedlander R.M, Gagliardini V, Ayata C, Fink K, Huang Z, Shimizu-Sasamata M, Yuan J, and Moskowitz M.A. (1997). Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl. Acad. Sci. U.S.A. 94, 2007-2012.
32. Schabitz W.R, Li F, Irie K, Sandage B.W, Jr, Locke K.W, and Fisher M. (1999). Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia. Stroke. 30, 427-432.
33. Kawai T, and Akira S. (2007). Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med. 13, 460-469.
34. Bethea J.R, Castro M, Keane R.W, Lee T.T, Dietrich W.D, and Yezierski R.P. (1998). Traumatic spinal cord injury induces nuclear factor-kappaB activation. J. Neurosci. 18, 3251-3260.
35. Madrigal J.L, Moro M.A, Lizasoain I, Lorenzo P, Castrillo A, Bosca L, and Leza J.C. (2001). Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor kappaB-mediated mechanisms. J. Neurochem. 76, 532-538.
36. La Rosa G, Cardali S, Genovese T, Conti A, Di Paola R, La Torre D, Cacciola F, and Cuzzocrea S. (2004). Inhibition of the nuclear factor-kappaB activation with pyrrolidine dithiocarbamate attenuating inflammation and oxidative stress after experimental spinal cord trauma in rats. J. Neurosurg. Spine. 1, 311-321.
37. Clark R.S, Bayir H, Chu C.T, Alber S.M, Kochanek P.M, and Watkins S.C. (2008). Autophagy is increased in mice after traumatic brain injury and is detectable in human brain after trauma and critical illness. Autophagy. 4, 88-90.
38. Liu C.L, Chen S, Dietrich D, and Hu B.R. (2008). Changes in autophagy after traumatic brain injury. J. Cereb. Blood Flow Metab. 28, 674-683.
39. Ichimura Y, Kumanomidou T, Sou Y.S, Mizushima T, Ezaki J, Ueno T, Kominami E, Yamane T, Tanaka K, and Komatsu M. (2008). Structural basis for sorting mechanism of p62 in selective autophagy. J.Biol. Chem. 283, 22847-22857.
40. Yu T.S, Zhang G, Liebl D.J, and Kernie S.G. (2008). Traumatic brain injury-induced hippocampal neurogenesis requires activation of early nestin-expressing progenitors. J. Neurosci. 28, 12901-12912.
41. Di Giovanni S, Movsesyan V, Ahmed F, Cernak I, Schinelli S, Stoica B, and Faden A.I. (2005). Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc. Natl. Acad. Sci. U.S.A. 102, 8333-8338.
42. Yamaoka S, Courtois G, Bessia C, Whiteside S.T, Weil R, Agou F, Kirk H.E, Kay R.J, and Israel A. (1998). Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell. 93, 1231-1240.
43. Liu F, Xia Y, Parker A.S, and Verma I.M. (2012). IKK biology. Immunol. Rev. 246, 239-253.
44. Luo Y, Umegaki H, Wang X, Abe R, and Roth G.S. (1998). Dopamine induces apoptosis through an oxidation-involved SAPK/.JNK activation pathway. J Biol. Chem. 273, 3756-3764.
45. Culmsee C, and Mattson M.P. (2005). p53 in neuronal apoptosis. Biochem. Biophys. Res. Commun. 331, 761-777.
46. Schmidt O.I, Heyde C.E, Ertel W, and Stahel P.F. (2005). Closed head injury-An inflammatory disease? Brain Res. Brain Res. Rev. 48, 388-399.
47. Lenz A, Franklin G.A, and Cheadle W.G. (2007). Systemic inflammation after trauma. Injury. 38, 1336-1345.
48. Venkatesan C, Chrzaszcz M, Choi N, and Wainwright M.S. (2010). Chronic upregulation of activated microglia immunoreactive for galectin-3/Mac-2 and nerve growth factor following diffuse axonal injury. J. Neuroinflammation. 7, 32.
49. Hernandez-Ontiveros D.G, Tajiri N, Acosta S, Giunta B, Tan J, and Borlongan C.V. (2013). Microglia activation as a biomarker for traumatic brain injury. Front. Neurol. 4, 30.
50. Ahmad A, Crupi R, Campolo M, Genovese T, Esposito E, and Cuzzocrea S. (2013). Absence of TLR4 reduces neurovascular unit and secondary inflammatory process after traumatic brain injury in mice. PloS One 8, e57208.
51. Bush T.G, Puvanachandra N, Horner C.H, Polito A, Ostenfeld T, Svendsen C.N, Mucke L, Johnson M.H, and Sofroniew M.V. (1999). Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron. 23, 297-308.
52. Giulian D, Haverkamp L.J, Li J, Karshin W.L, Yu J, Tom D, Li X, and Kirkpatrick J.B. (1995). Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain. Neurochem. Int. 27, 119-137.
53. Rockwell P, Martinez J, Papa L, and Gomes E. (2004). Redox regulates COX-2 upregulation and cell death in the neuronal response to cadmium. Cell. Signal. 16, 343-353.
54. Orihara Y, Ikematsu K, Tsuda R, and Nakasono I. (2001). Induction of nitric oxide synthase by traumatic brain injury. Forensic Sci. Int. 123, 142-149.
55. Iadecola C, Zhang F, Casey R, Clark H.B, and Ross M.E. (1996). Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke. 27, 1373-1380.
56. Singh I.N, Sullivan P.G, and Hall E.D. (2007). Peroxynitrite-mediated oxidative damage to brain mitochondria: Protective effects of peroxynitrite scavengers. J. Neurosci. Res. 85, 2216-2223.
57. Ola M.S, Nawaz M, and Ahsan H. (2011). Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol. Cell. Biochem. 351, 41-58.
58. Reed J.C. (2006). Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities. Cell Death Differ. 13, 1378-1386.
59. Beer R, Franz G, Schopf M, Reindl M, Zelger B, Schmutzhard E, Poewe W, and Kampfl A. (2000). Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat. J. Cereb. Blood Flow Metab. 20, 669-677.
60. Conti A.C, Raghupathi R, Trojanowski J.Q, and McIntosh T.K. (1998). Experimental brain injury induces regionally distinct apoptosis during the acute and delayed post-Traumatic period. J. Neurosci. 18, 5663-5672.
61. Yakovlev A.G, Knoblach S.M, Fan L, Fox G.B, Goodnight R, and Faden A.I. (1997). Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J. Neurosci. 17, 7415-7424.
62. Baehrecke E.H. (2002). How death shapes life during development. Nat. Rev. Mol. Cell Biol. 3, 779-787.
63. Reggiori F, and Klionsky D.J. (2005). Autophagosomes: biogenesis from scratch? Curr. Opin. Cell Biol. 17, 415-422.
64. Pyronnet S, and Sonenberg N. (2001). Cell-cycle-dependent translational control. . Opin. Genet. Dev. 11, 13-18.
65. Schmelzle T. and Hall M.N. (2000). TOR, a central controller of cell growth. Cell. 103, 253-262.
66. Park J.M, Huang S, Wu T.T, Foster N.R, and Sinicrope F.A. (2013). Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy. Cancer Biol. Ther. 14, 100-107.